Prosecution Insights
Last updated: November 20, 2026

Etsub D Berhanu, USPTO Patent Examiner

Listed by the USPTO as BERHANU, ETSUB D

Tech Center 3700 • Art Units: 3735 3768 3791

This examiner grants 65% of resolved cases

Analysis

Etsub D. Berhanu is assigned to Tech Center 3700 and Art Unit 3735. Across 813 resolved cases, the allowance rate is 65.2%, the interview lift is 24.9%, and the median time to allowance is 1,301 days. The positive interview measure indicates better allowance outcomes for interviewed cases than for the profile’s non-interview baseline.

The substantial case volume supports using the profile for prosecution planning. The allowance rate indicates that successful outcomes occur regularly, while the median timing shows that the path to allowance may be extended. Interviews appear useful as part of a coordinated strategy, especially when they address a specific claim distinction or evidentiary gap. The most frequent companies are Abbott Laboratories, Medtronic Inc., and Persyst Development Corporation. Frequently appearing firms are STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., ARENTFOX SCHIFF LLP, and Clause Eight. Practitioners should align interview discussion, amendments, and technical evidence.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.2%
Allow Rate
-4.8% vs TC avg
864
Total Applications
+24.9%
Interview Lift
1301
Avg Prosecution Days
Based on 813 resolved cases, 2023–2026

Rejection Statute Breakdown

19.1%
§101 Eligibility
10.4%
§102 Novelty
31.2%
§103 Obviousness
32.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17877867 AUTONOMOUS SURGICAL SENSORS AND COMMUNICATION NETWORK Non-Final OA Covidien LP
18488432 ELECTROENCEPHALOGRAPHIC DATA ANALYSIS SYSTEM, INFORMATION PROCESSING TERMINAL, ELECTRONIC DEVICE, AND METHOD OF PRESENTING INFORMATION FOR DEMENTIA EXAMINATION Non-Final OA MAXELL, LTD.
18724271 EVALUATION DEVICE, EVALUATION METHOD, AND RECORDING MEDIUM Final Rejection NEC Corporation
18691486 DATA GENERATION DEVICE, LEARNING SYSTEM, ESTIMATION SYSTEM, DATA GENERATION METHOD, AND RECORDING MEDIUM Non-Final OA NEC Corporation
18182630 ATROPHY DETECTION FOR TISSUE OCCLUDED BY IMPLANTABLE INFLATION DEVICES Non-Final OA Boston Scientific Scimed, Inc.
18084944 BED HAVING FEATURES TO PASSIVELY MONITOR BLOOD PRESSURE Final Rejection SNBR INC.
19023815 SCREENING, DIAGNOSIS AND MONITORING OF RESPIRATORY DISORDERS Non-Final OA ResMed Pty Ltd
18496373 NOTIFICATION INDICATIVE OF A CHANGE IN EFFICACY OF THERAPY Final Rejection Medtronic, Inc.
17459466 DETECTION OF SEIZURE AND STROKE Final Rejection Medtronic, Inc.
16293325 SYSTEM AND METHOD FOR MONITORING AND CONTROLLING A STATE OF A PATIENT DURING AND AFTER ADMINISTRATION OF ANESTHETIC COMPOUND Final Rejection The General Hospital Corporation
18929228 HEALTH MANAGEMENT DEVICES AND METHODS Non-Final OA Abbott Diabetes Care Inc.
18821590 SENSOR FOR DETECTING GLUCOSE AND LACTATE AND METHODS FOR DETERMINING AEROBIC AND ANAEROBIC THRESHOLDS Non-Final OA ABBOTT DIABETES CARE INC.
18784287 ANALYTE MONITORING SYSTEM AND METHODS OF USE Non-Final OA ABBOTT DIABETES CARE INC.
18674805 METHODS FOR INCORPORATING THERAPEUTIC AGENTS INTO ANALYTE SENSORS Non-Final OA ABBOTT DIABETES CARE INC.
18908057 SENSOR IMPLANT DEVICE WITH STABILIZING APPENDAGE Non-Final OA EDWARDS LIFESCIENCES CORPORATION
19182834 MASTICATORY MOVEMENT ANALYSIS METHOD Non-Final OA Meiji Co., Ltd.
18667395 ANORECTAL TONOMETER FOR NEUROLOGICAL TESTING Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
18717322 BLOOD FLOW RESTRICTIVE CUFF WITH INTEGRATED BLOOD FLOW SENSOR Non-Final OA KCI Manufacturing Unlimited Company
16987346 SYSTEM AND METHOD FOR COMMUNICATING BRAIN ACTIVITY TO AN IMAGING DEVICE Non-Final OA Neuroenhancement Lab, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Etsub D Berhanu's allowance rate?

65.2% of resolved applications examined by Etsub D Berhanu were allowed (813 resolved cases), compared with 39.4% across Art Unit 3735 over the last five years.

Does an interview help with examiner Etsub D Berhanu?

This examiner's interview lift is +24.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Etsub D Berhanu take to allow a patent?

Applications allowed by Etsub D Berhanu took 1,301 days on average from filing to allowance.

Which art unit does examiner Etsub D Berhanu work in?

Etsub D Berhanu examines applications in Art Unit 3735 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month